Literature DB >> 9250410

Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens.

S F Sarabia1, B T Zhu, T Kurosawa, M Tohma, J G Liehr.   

Abstract

The mechanism of aromatic hydroxylation of estrogens by cytochrome P450 enzymes has been examined by comparing the oxidation of estrone with that of substrates carrying additional aromaticity such as equilenin and the structural analog 2-naphthol. Hamster liver microsomes preferentially catalyzed the conversion of estrone to 2-hydroxyestrone (Km = 30 and 25 microM and Vmax = 1497 and 900 pmol (mg of protein)-1 min-1 for 2- and 4-hydroxyestrone formation, respectively). In contrast, equilenin was hydroxylated exclusively at C-4 of the steroid ring system and 2-naphthol at the corresponding C-1 position (Km = 67 and 42 microM and Vmax = 2083 and 3226 pmol (mg of protein)-1 min-1 for 4-hydroxyequilenin and 1,2-dihydroxynaphthalene formation, respectively). This shift in the specificity of hydroxylation was due to the introduction of additional aromaticity at ring B of equilenin, because hamster liver microsomes are known not to contain any estrogen-4-hydroxylase, only estrogen-2-hydroxylase activity catalyzed by cytochrome P450 3A family enzymes. The exclusive 4-hydroxylation of equilenin is proposed to be due to a preferred delocalization of the naphthoxy radical an intermediate in the hydroxylation, to C-4, whereas delocalization to C-2 requires additional activation energy and is energetically not favored. Based on these electronic considerations, a mechanism of aromatic hydroxylation of estrogens is proposed which features hydrogen abstraction from the phenolic hydroxy group, electron delocalization of the phenoxy radical to a carbon-centered radical, and subsequent formation of catechol metabolites by hydroxy radical addition at C-2 or C-4 depending on steric or electronic constraints.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9250410     DOI: 10.1021/tx970021f

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

1.  The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.

Authors:  Teshome B Gherezghiher; Bradley Michalsen; R Esala P Chandrasena; Zhihui Qin; Johann Sohn; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2012-01-28       Impact factor: 5.192

2.  Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.

Authors:  Zhican Wang; Esala R Chandrasena; Yang Yuan; Kuan-wei Peng; Richard B van Breemen; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2010-08-16       Impact factor: 3.739

Review 3.  Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Authors:  Tamara S Dowers; Zhi-Hui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2006-09       Impact factor: 3.739

4.  Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.

Authors:  Karma C Fussell; Ronald G Udasin; Peter J S Smith; Michael A Gallo; Jeffrey D Laskin
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

5.  Development of a liquid chromatography electrospray ionization tandem mass spectrometry method for analysis of stable 4-hydroxyequilenin-DNA adducts in human breast cancer cells.

Authors:  Zhican Wang; Praneeth Edirisinghe; Johann Sohn; Zhihui Qin; Nicholas E Geacintov; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

Review 6.  Potential mechanisms of estrogen quinone carcinogenesis.

Authors:  Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2007-12-04       Impact factor: 3.739

7.  Cytochrome P450 CYP3A in human renal cell cancer.

Authors:  G I Murray; M C McFadyen; R T Mitchell; Y L Cheung; A C Kerr; W T Melvin
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 8.  Selective estrogen receptor modulators: tissue specificity and clinical utility.

Authors:  Stephen Martinkovich; Darshan Shah; Sonia Lobo Planey; John A Arnott
Journal:  Clin Interv Aging       Date:  2014-08-28       Impact factor: 4.458

9.  Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFκβ interplay.

Authors:  Aarifa Nazmeen; Guangping Chen; Tamal Kanti Ghosh; Smarajit Maiti
Journal:  Cancer Cell Int       Date:  2020-03-04       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.